On behalf of the Program Committee and the ISPE Board of Directors, I am pleased to invite you to join your pharmaceutical industry peers for the 2017 Pharmaceutical Serialization Workshops, 8 – 9 May in Philadelphia, Pennsylvania. Serialization is a reality – now what? This unique event combines the benefits of a conference experience with ten interactive workshops in two tracks focused on practical readiness and operationalization issues. The workshops will also cover more advanced topics such as supply chain rationalization, data portability, and network continuous improvement supporting your company to maximize assets across global supply chains. Key industry issues that will be addressed include:
Featured speakers include FDA and MHRA regulators who will address compliance questions, as well as industry experts with years of practical experience working on global serialization implementation issues in a complex regulatory environment. Organizations represented include:
Serialization has the ability to capture key supply chain data that can be used to maximize your investments and revolutionize the way you do business. We look forward to seeing you in May! For more information, and to register, visit the 2017 Pharmaceutical Serialization Workshops conference website.
Best Regards
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...